Back to User profile » Dr Helgi van de Velde

Papers published by Dr Helgi van de Velde:


Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ

OncoTargets and Therapy 2018, 11:3869-3882

Published Date: 6 July 2018

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib

Richardson PG, Kumar S, Laubach JP, Paba-Prada C, Gupta N, Berg D, van de Velde H, Moreau P

Journal of Blood Medicine 2017, 8:107-121

Published Date: 22 August 2017